BBC World reporter Gabriela Torres has met Liz to learn about BioViva's project to make cutting edge therapies, that have been proven safe in animals, available for humans in the near future at an affordable price.
Source : BBC World
Liz Parrish warns against the consequences of excessive regulatory precautions. In our current world of exponential medical progress not taking risks can cause more deaths than being less risk averse.
"“As a matter of fact, not intervening in one’s health is more reckless because we already know how we’ll die. We can actually use this powerful technology to treat what we call complex disease, which is many of the diseases of childhood and ageing.”
David Roos presents Liz Parrish's project of curing aging with gene therapy on Seeker website.
“From diagnosing aging related dysfunctions, to predicting future ill health, preventing sickness using gene and cell therapies, and maintaining optimal health using advanced nutritional support --- we deeply care about the health and well being of all, and using our clinics and our products we want to deliver personalized, precision, preventive, and participatory medicine to the masses.”
Read MoreOn October 27th 2017 The Economist magazine held a conference on the economic impact of extreme Longevity, bringing together leading minds to discuss how society can make the transition to an older but still productive population.
Our CEO, Liz Parrish was invited at this event for a keynote interview with Charles Goddard, the editorial director for The Economist Asia Pacific Intelligence Unit. They discussed the complexity of regulations, the extraordinarily long time it takes for drug development from bench to bedside, the current funding environment surrounding biotech, and the pace of medical innovations. During the keynote, Liz emphasized that BioViva’s main aim is to make advanced gene and cell therapies available to all patients in need. To further this cause BioViva supports innovative and adaptive clinical trials, new models for preclinical testing, and accelerating the time to develop advanced gene and cell therapy. Finally, Liz highlighted the importance of testing gene and cell therapy in humans as quickly as possible, because animal models are not accurate.
“People need to understand that this is not aesthetics—this is survival.”
Read MoreBBC World Service interviews BioViva's CEO Liz Parrish for 'Forever Young', a documentary on pioneers and self experimentation in the world of longevity. Liz explains why self experimentation and calculated risk taking has an important role in accelerating progress today, and why risk-avoidance is perhaps the riskiest behaviour of all.
Read More
Credit: Justin Kaneps
From fighting aging, to boosting athletic ability and tackling cancer, gene therapies are ushering in an exciting new era. Read all about the biohacking phenomenon as BioViva is mentioned in Outside’s latest feature on the growing Biohacking movement:
‘In 2015, Liz Parrish, the CEO of the startup BioViva, announced that she was the first person to attempt to reverse her own aging with gene therapy. “I am patient zero,” she wrote on Reddit. “I will be 45 in January. I have aging as a disease.” ’
Source: Outside
Globalive Chairman Anthony Lacavera interviews BioViva's CEO Liz Parrish. Liz covers the pressing need for novel medical innovations to target the aging process, why BioViva's gene therapy represents a smarter approach, and how a combination of regenerative therapies will drive the future of healthcare.
Source: Bloomberg
A host of researchers and companies across the globe are beginning to develop and market treatments targeting the aging process for the first time. Catch a mention of BioViva's work in the latest round up from Futurism.
Liz Parrish, CEO and Founder of BioViva, on Digital Health Today. Liz discusses the need for innovation solutions to aging and age-related disease, the importance of classifying aging as a disease, and BioViva's work developing gene and cell therapies to prevent, delay and reverse biological aging.
Liz spoke at L'Echappée Volée in May about BioViva's gene therapies and the need for innovative new solutions to the problem of aging and age-related disease. Catch a preview of the final talk which will be uploaded soon here. In this article Le Monde discusses the event, summarizing Liz's appearance and her receipt of BioViva's dual gene therapies.
Last week, Liz Parrish, BioViva's founder and CEO, sat down for a chat with the French publication Soon Soon Soon. During the interview Liz discussed about her vision of a world without suffering from disease, the technologies that will bring that world to fruition, and how BioViva will help.
Unfortunately, the interview and the Q&A is in French, but google translate does a pretty good job of translating it to English.
See the entire original article: Le monde de demain selon Liz Parrish, Fondatrice de BioViva
See the Google Translated English version of this article: The World of Tomorrow According to Liz Parrish, Founder of BioViva
Our CEO, Liz Parrish, spoke at the Wired Health conference in London last month. At the conference Liz spoke about how her son being diagnosed with Type 1 Diabetes was the motivation behind her researching gene therapy treatments for cures. She also spoke about how and why she tested gene therapies on herself. Finally, Liz discussed the importance of making gene therapy more widely available and how it could ‘cure’ the most prevalent disease of all; aging.
Read MoreBioViva and our CEO, Elizabeth Parrish, have been featured in the latest National Geographic article about the future of human evolution and how technology is accelerating it. We have chosen some of our favorite sections from the article but we recommend you read the whole thing. Please see the link to the article below.
"Like other species, we are the products of millions of years of adaptation. Now we're taking matters into our own hands."
'Last year the CEO of a company called BioViva claimed to have successfully reversed some of the effects of aging in her own body with injections from a gene therapy her company devised.'
'Aging reversal is just as augmentative as anything else we were talking about. Whatever drugs work to prevent Alzheimer’s will probably also work for cognitive enhancement, and they will work in adults almost by definition. DNA was left in the dust by cultural evolution”, George Church says, "but now it’s catching up.”
NEAR FUTURE: SCIENCE FICTION BECOMES REALITY (Source: Max, D.T. "How Humans Are Shaping Our Own Evolution." National Geographic. N.p., 04 Apr. 2017. Web. 06 Apr. 2017.
“We will transcend all of the limitations of our biology,” Kurzweil promised. “That is what it means to be human—to extend who we are.”
"....using genetically engineered viruses to force old mice to make more telomerase results in a longer lifespan with improved late-life health, without an increased risk of cancer.
Elizabeth Parrish, who is the CEO of BioViva – a company working to develop anti-ageing treatments – recently travelled to Colombia to receive gene therapy to extend her telomeres."
Elizabeth Parrish is the founder and CEO of BioViva, a biotech company which advocates gene and cell therapies to treat the diseases of aging. She is a major advocate of patient access to these revolutionary treatments, and became a test subject in September 2015 after receiving treatment for what she believes is the most common 'disease' - aging. To combat the process of aging, she subjected herself to two kinds of therapy - telomerase therapy and myostatin inhibitor.
"She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent."
“I was a person who quite honestly felt I had not really contributed that much to society and this was my opportunity to do so.”
“The company was built essentially to prove these therapies work or not,” Parrish says. “Remember BioViva is not a research organisation. We are taking things like gene therapies and using them like technology. We would like to create an open market where people have access to acquiring these technologies, much like you would acquire a cellphone or a computer.”
To go to Liz's section in this show click this link: https://youtu.be/E79mOjWDOIY?t=1444
Liz Parrish, CEO of BioViva, speaks about helping people live longer healthier lives by using gene and cell therapies. Liz was speaking at Norways NRK TV show Trygdekontoret.
Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup of speakers brought an infectious enthusiasm for action in healthcare.
Changing disease through genetic therapies. We work on anti aging / age reversing gene therapies to mitigate the diseases of old age. BioViva Sciences - the cure is the the Helix of Humanity.
We are gene therapy innovation leaders. We develop platforms
to treat severe genetic disorders and cellular aging.
Seattle WA©2022. BioViva All rights reserved | For any inquires, contact info@bioviva-science.com
facebook
twitter
instagram
linkedin
youtube